US5733572A
(en)
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
US5580575A
(en)
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
US6146657A
(en)
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
US5922304A
(en)
*
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
US5305757A
(en)
|
1989-12-22 |
1994-04-26 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US20020150539A1
(en)
*
|
1989-12-22 |
2002-10-17 |
Unger Evan C. |
Ultrasound imaging and treatment
|
US5656211A
(en)
|
1989-12-22 |
1997-08-12 |
Imarx Pharmaceutical Corp. |
Apparatus and method for making gas-filled vesicles of optimal size
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
US6001335A
(en)
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
US5776429A
(en)
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
US5370901A
(en)
*
|
1991-02-15 |
1994-12-06 |
Bracco International B.V. |
Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
|
US5874062A
(en)
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
GB9221329D0
(en)
|
1992-10-10 |
1992-11-25 |
Delta Biotechnology Ltd |
Preparation of further diagnostic agents
|
US5981568A
(en)
|
1993-01-28 |
1999-11-09 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US6528067B1
(en)
|
1993-02-22 |
2003-03-04 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
JP3746293B2
(en)
*
|
1993-02-22 |
2006-02-15 |
アメリカン バイオサイエンス、インコーポレイテッド |
Methods for in vivo delivery of biologics and compositions therefor
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
US20030133955A1
(en)
*
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
US20030073642A1
(en)
*
|
1993-02-22 |
2003-04-17 |
American Bioscience, Inc. |
Methods and formulations for delivery of pharmacologically active agents
|
US5997904A
(en)
*
|
1993-02-22 |
1999-12-07 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US20070122465A1
(en)
*
|
1993-02-22 |
2007-05-31 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
US5916596A
(en)
*
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US6537579B1
(en)
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
US20030068362A1
(en)
*
|
1993-02-22 |
2003-04-10 |
American Bioscience, Inc. |
Methods and formulations for the delivery of pharmacologically active agents
|
US5855865A
(en)
*
|
1993-07-02 |
1999-01-05 |
Molecular Biosystems, Inc. |
Method for making encapsulated gas microspheres from heat denatured protein in the absence of oxygen gas
|
US7083572B2
(en)
*
|
1993-11-30 |
2006-08-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Therapeutic delivery systems
|
WO1995024929A2
(en)
*
|
1994-03-15 |
1995-09-21 |
Brown University Research Foundation |
Polymeric gene delivery system
|
US20010055581A1
(en)
|
1994-03-18 |
2001-12-27 |
Lawrence Tamarkin |
Composition and method for delivery of biologically-active factors
|
US5736121A
(en)
|
1994-05-23 |
1998-04-07 |
Imarx Pharmaceutical Corp. |
Stabilized homogenous suspensions as computed tomography contrast agents
|
US6159445A
(en)
*
|
1994-07-20 |
2000-12-12 |
Nycomed Imaging As |
Light imaging contrast agents
|
US5965109A
(en)
*
|
1994-08-02 |
1999-10-12 |
Molecular Biosystems, Inc. |
Process for making insoluble gas-filled microspheres containing a liquid hydrophobic barrier
|
AUPM922594A0
(en)
|
1994-11-04 |
1994-11-24 |
Commonwealth Scientific And Industrial Research Organisation |
Reduction of methane production in animals
|
GB9423419D0
(en)
*
|
1994-11-19 |
1995-01-11 |
Andaris Ltd |
Preparation of hollow microcapsules
|
US6333021B1
(en)
|
1994-11-22 |
2001-12-25 |
Bracco Research S.A. |
Microcapsules, method of making and their use
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US6540981B2
(en)
|
1997-12-04 |
2003-04-01 |
Amersham Health As |
Light imaging contrast agents
|
GB9502065D0
(en)
*
|
1995-02-02 |
1995-03-22 |
Nycomed Imaging As |
Contrast media
|
US5830430A
(en)
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
US5916790A
(en)
*
|
1995-03-03 |
1999-06-29 |
Metabolex, Inc. |
Encapsulation compositions, and methods
|
WO1996027662A1
(en)
*
|
1995-03-03 |
1996-09-12 |
Metabolex, Inc. |
Novel encapsulation process by a gelling polymer
|
GB9506844D0
(en)
*
|
1995-04-03 |
1995-05-24 |
Armitage Ian M |
Pharmaceutical microencapsulation
|
AU693354B2
(en)
*
|
1995-04-10 |
1998-06-25 |
Baxter International Inc. |
The use of cross-linked hemoglobin in treating subarachnoid hemorrhage
|
US5834012A
(en)
*
|
1995-05-03 |
1998-11-10 |
Roman Perez-Soler |
Lipid complexed topoisomerase I inhibitors
|
US5997898A
(en)
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
US6139819A
(en)
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
US5804162A
(en)
|
1995-06-07 |
1998-09-08 |
Alliance Pharmaceutical Corp. |
Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
|
US7611533B2
(en)
*
|
1995-06-07 |
2009-11-03 |
Cook Incorporated |
Coated implantable medical device
|
JP2001515458A
(en)
*
|
1995-06-07 |
2001-09-18 |
マリンクロッド・インコーポレイテッド |
Gaseous ultrasonic contrast agent and imaging method
|
US20020119102A1
(en)
*
|
1996-06-05 |
2002-08-29 |
Alexey Kabalnov |
Gas emulsions stabilized with fluorinated ethers having low ostwald coefficients
|
US6033645A
(en)
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
WO2004073750A1
(en)
*
|
1995-06-07 |
2004-09-02 |
Harald Dugstad |
Improvements in or relating to contrast agents
|
US6565842B1
(en)
|
1995-06-07 |
2003-05-20 |
American Bioscience, Inc. |
Crosslinkable polypeptide compositions
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
FR2736930B1
(en)
*
|
1995-07-17 |
1997-09-19 |
Biocem |
PROCESS FOR THE PRODUCTION, BY PLANT CELLS, OF HEMINIC PROTEINS, PROTEINS THUS OBTAINED AND PRODUCTS CONTAINING THE SAME
|
US6143211A
(en)
*
|
1995-07-21 |
2000-11-07 |
Brown University Foundation |
Process for preparing microparticles through phase inversion phenomena
|
US6248720B1
(en)
|
1996-07-03 |
2001-06-19 |
Brown University Research Foundation |
Method for gene therapy using nucleic acid loaded polymeric microparticles
|
WO1997003702A1
(en)
|
1995-07-21 |
1997-02-06 |
Brown University Research Foundation |
A method for gene therapy using nucleic acid loaded polymeric microparticles
|
US5733869A
(en)
*
|
1995-10-06 |
1998-03-31 |
Baxter International, Inc. |
Therapeutic administration of hemoglobin in cardiac arrest
|
WO1997017063A1
(en)
†
|
1995-11-09 |
1997-05-15 |
Microbiological Research Authority |
Microencapsulated dna for vaccination and gene therapy
|
US6270795B1
(en)
*
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
US5985312A
(en)
*
|
1996-01-26 |
1999-11-16 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
US6368586B1
(en)
|
1996-01-26 |
2002-04-09 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
US5767297A
(en)
*
|
1997-02-05 |
1998-06-16 |
Ensuiko Sugar Refining Co., Ltd. |
Taxoid derivative and method of producing thereof
|
US5753477A
(en)
*
|
1996-03-19 |
1998-05-19 |
University Technology Corporation |
Magneto-biolistic methods
|
US5869539A
(en)
*
|
1996-04-17 |
1999-02-09 |
Board Of Regents, The University Of Texas System |
Emulsions of perfluoro compounds as solvents for nitric oxide (NO)
|
WO1997040679A1
(en)
|
1996-05-01 |
1997-11-06 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US6184037B1
(en)
*
|
1996-05-17 |
2001-02-06 |
Genemedicine, Inc. |
Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell
|
US5773461A
(en)
*
|
1996-06-06 |
1998-06-30 |
Bristol-Myers Squibb Company |
7-deoxy-6-substituted paclitaxels
|
EP0910351A1
(en)
*
|
1996-06-27 |
1999-04-28 |
G.D. Searle & Co. |
Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications
|
US5849727A
(en)
*
|
1996-06-28 |
1998-12-15 |
Board Of Regents Of The University Of Nebraska |
Compositions and methods for altering the biodistribution of biological agents
|
US5837221A
(en)
*
|
1996-07-29 |
1998-11-17 |
Acusphere, Inc. |
Polymer-lipid microencapsulated gases for use as imaging agents
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
US6017310A
(en)
*
|
1996-09-07 |
2000-01-25 |
Andaris Limited |
Use of hollow microcapsules
|
US5846517A
(en)
*
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
EP0977597B1
(en)
*
|
1996-09-11 |
2003-01-15 |
Imarx Pharmaceutical Corp. |
Improved methods for diagnostic imaging using a contrast agent and a vasodilator
|
US8137684B2
(en)
|
1996-10-01 |
2012-03-20 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
US6083484A
(en)
*
|
1996-10-17 |
2000-07-04 |
Molecular Biosystems, Inc. |
Microparticles stabilized by polynuclear chromium complexes and their use as ultrasound contrast agents
|
US6264917B1
(en)
*
|
1996-10-28 |
2001-07-24 |
Nycomed Imaging As |
Targeted ultrasound contrast agents
|
US6331289B1
(en)
*
|
1996-10-28 |
2001-12-18 |
Nycomed Imaging As |
Targeted diagnostic/therapeutic agents having more than one different vectors
|
US9107949B2
(en)
|
1996-11-12 |
2015-08-18 |
The University Of Akron |
Method for using naturally occurring gas vesicles as ultrasound contrast agent
|
US5804551A
(en)
*
|
1996-11-12 |
1998-09-08 |
Baxter International Inc. |
Pretraumatic use of hemoglobin
|
EP0956337A4
(en)
*
|
1996-11-12 |
2004-12-22 |
Univ Akron |
Compositions and methods relating to the production, isolation, and modification of gas vesicles
|
US6413763B1
(en)
*
|
1996-11-12 |
2002-07-02 |
The University Of Akron |
Method of removing gas from a site using gas vesicles of cells
|
AU5161298A
(en)
*
|
1996-11-25 |
1998-06-22 |
Imarx Pharmaceutical Corp. |
Perfluorinated-ether compositions as diagnostic contrast agents
|
US6068600A
(en)
*
|
1996-12-06 |
2000-05-30 |
Quadrant Healthcare (Uk) Limited |
Use of hollow microcapsules
|
US20030105156A1
(en)
*
|
1997-01-07 |
2003-06-05 |
Nagesh Palepu |
Method for administration of a taxane/tocopherol formulation to enhance taxane therapeutic utility
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
US6537246B1
(en)
*
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
US6143276A
(en)
*
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
US6090800A
(en)
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
US6048551A
(en)
*
|
1997-03-27 |
2000-04-11 |
Hilfinger; John M. |
Microsphere encapsulation of gene transfer vectors
|
JP2001521503A
(en)
*
|
1997-03-31 |
2001-11-06 |
ネオルックス コーポレイション |
Therapeutic inhibitors of vascular smooth muscle cells
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
US20020039594A1
(en)
*
|
1997-05-13 |
2002-04-04 |
Evan C. Unger |
Solid porous matrices and methods of making and using the same
|
DE19720083A1
(en)
*
|
1997-05-14 |
1998-11-19 |
Silvia Zender |
Pharmaceutical composition comprises cotton wool seed oil
|
US6245318B1
(en)
*
|
1997-05-27 |
2001-06-12 |
Mallinckrodt Inc. |
Selectively binding ultrasound contrast agents
|
CA2206739C
(en)
*
|
1997-06-03 |
2006-10-10 |
Ensuiko Sugar Refining Co., Ltd. |
Taxoid derivative and method of producing thereof
|
US8853260B2
(en)
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
US20030199425A1
(en)
*
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
CN101579335B
(en)
*
|
1997-06-27 |
2016-08-03 |
阿布拉科斯生物科学有限公司 |
The preparation of medicament and methods for making and using same thereof
|
CN100462066C
(en)
*
|
1997-06-27 |
2009-02-18 |
美国生物科学有限公司 |
Novel formulations of pharmacological agents, method for preparation thereof and method for use thereof
|
US6045777A
(en)
*
|
1997-06-30 |
2000-04-04 |
Acusphere, Inc. |
Method for enhancing the echogenicity and decreasing the attenuation of microencapsulated gases
|
US6977074B2
(en)
*
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
CA2297489A1
(en)
|
1997-07-30 |
1999-02-11 |
Emory University |
Novel bone mineralization proteins, dna, vectors, expression systems
|
US7923250B2
(en)
|
1997-07-30 |
2011-04-12 |
Warsaw Orthopedic, Inc. |
Methods of expressing LIM mineralization protein in non-osseous cells
|
US7135191B2
(en)
*
|
1997-09-04 |
2006-11-14 |
Zsolt Istvan Hertelendy |
Urogenital or anorectal transmucosal vaccine delivery system
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
US6129912A
(en)
*
|
1997-09-26 |
2000-10-10 |
Uab Research Foundation |
Polyethylene glycol-protein compositions which reduce the antigenic display of red blood cells
|
US20030220234A1
(en)
*
|
1998-11-02 |
2003-11-27 |
Selvaraj Naicker |
Deuterated cyclosporine analogs and their use as immunodulating agents
|
US6726934B1
(en)
*
|
1997-10-09 |
2004-04-27 |
Vanderbilt University |
Micro-particulate and nano-particulate polymeric delivery system
|
WO1999022769A1
(en)
|
1997-10-31 |
1999-05-14 |
Monsanto Company |
Gellan gum tablet coating
|
US7229841B2
(en)
|
2001-04-30 |
2007-06-12 |
Cytimmune Sciences, Inc. |
Colloidal metal compositions and methods
|
US6407218B1
(en)
*
|
1997-11-10 |
2002-06-18 |
Cytimmune Sciences, Inc. |
Method and compositions for enhancing immune response and for the production of in vitro mabs
|
WO1999024016A1
(en)
*
|
1997-11-10 |
1999-05-20 |
Sonus Pharmaceuticals, Inc. |
Emulsions for aerosolization and drug delivery
|
US5851544A
(en)
*
|
1997-12-18 |
1998-12-22 |
Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. |
Cosmetic skin or hair care compositions containing fluorocarbons infused with carbon dioxide
|
US6123923A
(en)
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
US20030059465A1
(en)
*
|
1998-05-11 |
2003-03-27 |
Unger Evan C. |
Stabilized nanoparticle formulations of camptotheca derivatives
|
WO1999058134A1
(en)
*
|
1998-05-11 |
1999-11-18 |
Purdue Research Foundation |
Methods and compositions for nucleic acid delivery
|
US6169078B1
(en)
*
|
1998-05-12 |
2001-01-02 |
University Of Florida |
Materials and methods for the intracellular delivery of substances
|
US7427602B1
(en)
*
|
1998-05-13 |
2008-09-23 |
The Regents Of The University Of Michigan |
Sustained DNA delivery from structural matrices
|
US6406719B1
(en)
|
1998-05-13 |
2002-06-18 |
Microbiological Research Authority |
Encapsulation of bioactive agents
|
GB9810236D0
(en)
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
WO1999058149A1
(en)
*
|
1998-05-13 |
1999-11-18 |
Light Sciences Limited Partnership |
Controlled activation of targeted radionuclides
|
EP1002810A4
(en)
|
1998-06-04 |
2002-07-17 |
Kao Corp |
Polymer emulsion and process for producing the same
|
US6103275A
(en)
*
|
1998-06-10 |
2000-08-15 |
Nitric Oxide Solutions |
Systems and methods for topical treatment with nitric oxide
|
US20020022588A1
(en)
*
|
1998-06-23 |
2002-02-21 |
James Wilkie |
Methods and compositions for sealing tissue leaks
|
AU759641B2
(en)
*
|
1998-08-19 |
2003-04-17 |
Skyepharma Canada Inc. |
Injectable aqueous dispersions of propofol
|
US6485747B1
(en)
|
1998-10-30 |
2002-11-26 |
Monsanto Company |
Coated active tablet(s)
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
DE19852928C1
(en)
*
|
1998-11-17 |
2000-08-03 |
Steffen Panzner |
Structures in the form of hollow spheres
|
US6864301B2
(en)
*
|
1998-11-30 |
2005-03-08 |
The Regents Of The University Of Colorado |
Preparation and use of photopolymerized microparticles
|
US6040330A
(en)
*
|
1999-01-08 |
2000-03-21 |
Bionumerik Pharmaceuticals, Inc. |
Pharmaceutical formulations of taxanes
|
US6958212B1
(en)
*
|
1999-02-01 |
2005-10-25 |
Eidgenossische Technische Hochschule Zurich |
Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
|
ATE514729T1
(en)
*
|
1999-02-01 |
2011-07-15 |
Eidgenoess Tech Hochschule |
BIOMATERIALS ADDED BY NUCLEOPHILIC REACTION ON CONJUGATE UNSATURATED GROUPS
|
US6500807B1
(en)
|
1999-02-02 |
2002-12-31 |
Safescience, Inc. |
Modified pectin and nucleic acid composition
|
US6444192B1
(en)
*
|
1999-02-05 |
2002-09-03 |
The Regents Of The University Of California |
Diagnostic imaging of lymph structures
|
EP1156812A4
(en)
*
|
1999-02-23 |
2004-09-29 |
Isis Pharmaceuticals Inc |
Multiparticulate formulation
|
US6767928B1
(en)
|
1999-03-19 |
2004-07-27 |
The Regents Of The University Of Michigan |
Mineralization and biological modification of biomaterial surfaces
|
DE60003006T2
(en)
*
|
1999-03-19 |
2004-04-01 |
The Regents Of The University Of Michigan Technology Management Wolverine Tower, Ann Arbor |
MINERALIZATION AND CELLULAR STRUCTURING OF BIOMATERIAL SURFACES
|
US6398772B1
(en)
*
|
1999-03-26 |
2002-06-04 |
Coraje, Inc. |
Method and apparatus for emergency treatment of patients experiencing a thrombotic vascular occlusion
|
US7678390B2
(en)
*
|
1999-04-01 |
2010-03-16 |
Yale University |
Carbon monoxide as a biomarker and therapeutic agent
|
US6852334B1
(en)
*
|
1999-04-20 |
2005-02-08 |
The University Of British Columbia |
Cationic peg-lipids and methods of use
|
US6426145B1
(en)
|
1999-05-20 |
2002-07-30 |
Scimed Life Systems, Inc. |
Radiopaque compositions for visualization of medical devices
|
EP1102784A4
(en)
*
|
1999-06-07 |
2009-12-30 |
Mirus Bio Corp |
A compound containing a labile disulfide bond
|
WO2001019509A1
(en)
*
|
1999-09-10 |
2001-03-22 |
Zeneca Limited |
Variable release microcapsules
|
AU7743200A
(en)
*
|
1999-10-06 |
2001-05-10 |
Imarx Therapeutics, Inc. |
Improved methods for delivering bioactive agents
|
CA2386273C
(en)
*
|
1999-10-08 |
2009-03-31 |
Coty B.V. |
Cosmetic preparation of active substances with a synergistically increased radical protection factor
|
US20050037086A1
(en)
*
|
1999-11-19 |
2005-02-17 |
Zycos Inc., A Delaware Corporation |
Continuous-flow method for preparing microparticles
|
US7129329B1
(en)
*
|
1999-12-06 |
2006-10-31 |
University Of Hawaii |
Heme proteins hemAT-Hs and hemAT-Bs and their use in medicine and microsensors
|
JP2003522806A
(en)
*
|
2000-02-15 |
2003-07-29 |
ジェンザイム、コーポレーション |
Modification of biopolymers for improved drug delivery
|
US6749865B2
(en)
|
2000-02-15 |
2004-06-15 |
Genzyme Corporation |
Modification of biopolymers for improved drug delivery
|
CA2400172C
(en)
|
2000-02-28 |
2010-04-20 |
Genesegues, Inc. |
Nanocapsule encapsulation system and method
|
DE10010264A1
(en)
|
2000-03-02 |
2001-09-13 |
Novosom Gmbh |
Production of nano- or micro-capsules used in the production of liposomes coated with polyelectrolytes comprises electrically recharging template particles with polyelectrolytes
|
US7189705B2
(en)
*
|
2000-04-20 |
2007-03-13 |
The University Of British Columbia |
Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers
|
ITMI20001107A1
(en)
*
|
2000-05-18 |
2001-11-18 |
Acs Dobfar Spa |
METHOD FOR TREATMENT OF SOLIC TUMORS BY INCORPORATING PACLITAXEL MICROPARTICLES OF ALBUMIN
|
CA2410052A1
(en)
*
|
2000-06-02 |
2001-12-13 |
Zycos Inc. |
Delivery systems for bioactive agents
|
US7291673B2
(en)
*
|
2000-06-02 |
2007-11-06 |
Eidgenossiche Technische Hochschule Zurich |
Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
|
US20020076443A1
(en)
*
|
2000-06-19 |
2002-06-20 |
Stanley Stein |
Multiple phase cross-linked compositions and uses thereof
|
WO2002055185A2
(en)
*
|
2000-10-19 |
2002-07-18 |
Eidgenoess Tech Hochschule |
Block copolymers for multifunctional self-assembled systems
|
US20060280724A1
(en)
*
|
2000-11-04 |
2006-12-14 |
Ferguson Ian A |
Identification of ligands that enable endocytosis, using in vivo manipulation of neuronal fibers
|
DE10108799A1
(en)
*
|
2001-02-19 |
2002-09-05 |
Laser & Med Tech Gmbh |
Method and device for the ultrasonic vaccination of biological cell material
|
WO2002074158A2
(en)
*
|
2001-03-20 |
2002-09-26 |
Eidgenossische Technische Hochschule Zurich |
Two-phase processing of thermosensitive polymers for use as biomaterials
|
JP5175020B2
(en)
*
|
2001-04-30 |
2013-04-03 |
サイティミューン サイエンシーズ, インコーポレイテッド |
Colloidal metal compositions and methods
|
AU2002318377B2
(en)
*
|
2001-06-21 |
2008-06-19 |
Beth Israel Deaconess Medical Center, Inc. |
Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
|
CA2451432A1
(en)
*
|
2001-06-23 |
2003-01-03 |
Lyotropic Therapeutics, Inc. |
Particles with improved solubilization capacity
|
US6797257B2
(en)
*
|
2001-06-26 |
2004-09-28 |
The Board Of Trustees Of The University Of Illinois |
Paramagnetic polymerized protein microspheres and methods of preparation thereof
|
TWI252847B
(en)
*
|
2001-07-10 |
2006-04-11 |
Synta Pharmaceuticals Corp |
Synthesis of taxol enhancers
|
TWI297335B
(en)
|
2001-07-10 |
2008-06-01 |
Synta Pharmaceuticals Corp |
Taxol enhancer compounds
|
TWI332943B
(en)
*
|
2001-07-10 |
2010-11-11 |
Synta Pharmaceuticals Corp |
Taxol enhancer compounds
|
AU2002320348B2
(en)
*
|
2001-07-10 |
2007-07-19 |
Sonogene, Llc |
Enhancement of transfection of DNA into the liver
|
CN1335182A
(en)
*
|
2001-08-08 |
2002-02-13 |
华中科技大学 |
Insulin spray for oral cavity and its prepn process
|
US6746635B2
(en)
*
|
2001-08-08 |
2004-06-08 |
Brown University Research Foundation |
Methods for micronization of hydrophobic drugs
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
WO2003028657A2
(en)
*
|
2001-10-03 |
2003-04-10 |
The Johns Hopkins University |
Compositions for oral gene therapy and methods of using same
|
PL210795B1
(en)
|
2001-10-19 |
2012-03-30 |
Isotechnika Inc |
The method of producing the ISATX247 enriched isomer (E), the method of producing the ISATX247 enriched mixture of the (Z) isomer, the method of stereoselective synthesis of the (E) ISATX247 isomer, the method of stereoselective synthesis of the (Z) isomer ISATX247 and the method of producing the mixture of ISATX247 isomers
|
EP1460897A4
(en)
*
|
2001-12-10 |
2006-09-13 |
Spherics Inc |
Methods and products useful in the formation and isolation of microparticles
|
US20030147812A1
(en)
|
2001-12-11 |
2003-08-07 |
Friedrich Ueberle |
Device and methods for initiating chemical reactions and for the targeted delivery of drugs or other agents
|
JP3816809B2
(en)
*
|
2002-01-30 |
2006-08-30 |
株式会社日立製作所 |
Drug, drug carrier, drug production method and tumor treatment method
|
EP1480658B1
(en)
*
|
2002-02-13 |
2017-01-25 |
Beth Israel Deaconess Medical Center, Inc. |
Methods of treating vascular disease
|
IL148299A
(en)
*
|
2002-02-21 |
2014-04-30 |
Technion Res & Dev Foundation |
Ultrasound cardiac stimulator
|
DE10211886B4
(en)
*
|
2002-03-18 |
2004-07-15 |
Dornier Medtech Gmbh |
Method and device for generating bipolar acoustic pulses
|
US20030179692A1
(en)
*
|
2002-03-19 |
2003-09-25 |
Yoshitaka Ohotomo |
Storage medium
|
JP4842514B2
(en)
*
|
2002-03-20 |
2011-12-21 |
エラン ファーマ インターナショナル,リミティド |
Nanoparticle composition of angiogenesis inhibitor
|
US20080220075A1
(en)
*
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
US8282912B2
(en)
*
|
2002-03-22 |
2012-10-09 |
Kuros Biosurgery, AG |
Compositions for tissue augmentation
|
ITMI20020681A1
(en)
*
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
PROCEDURE FOR THE PRODUCTION OF PACLITAXEL AND ALBUMINA NANOPARTICLES
|
ITMI20020680A1
(en)
*
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
IMPROVED ANTI-TUMOR COMPOSITION BASED ON PACLITAXEL AND METHOD FOR ITS OBTAINING
|
US20040038303A1
(en)
*
|
2002-04-08 |
2004-02-26 |
Unger Gretchen M. |
Biologic modulations with nanoparticles
|
CA2482260A1
(en)
|
2002-04-15 |
2003-10-30 |
Beth Israel Deaconess Medical Center Inc. |
Use of heme oxygenase-1 and products of heme degradation
|
JP4588325B2
(en)
*
|
2002-04-15 |
2010-12-01 |
ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
How to treat ileus
|
CN1652802A
(en)
*
|
2002-04-15 |
2005-08-10 |
联邦高等教育系统匹兹堡大学 |
Methods of treating necrotizing enterocolitis
|
US20040126400A1
(en)
*
|
2002-05-03 |
2004-07-01 |
Iversen Patrick L. |
Delivery of therapeutic compounds via microparticles or microbubbles
|
US9031634B2
(en)
*
|
2002-05-17 |
2015-05-12 |
Christopher Flask |
Chemical shift markers for improved wireless fiducial marker tracking
|
WO2003096977A2
(en)
|
2002-05-17 |
2003-11-27 |
Yale University |
Methods of treating hepatitis
|
DE10223196B4
(en)
*
|
2002-05-24 |
2004-05-13 |
Dornier Medtech Systems Gmbh |
Method and device for transferring molecules into cells
|
US20040258772A1
(en)
*
|
2002-06-05 |
2004-12-23 |
Otterbein Leo E. |
Methods of treating angiogenesis, tumor growth, and metastasis
|
JP2005533812A
(en)
*
|
2002-06-21 |
2005-11-10 |
ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
Pharmaceutical use of nitric oxide, heme oxygenase-1 and heme degradation products
|
PL206379B1
(en)
*
|
2002-07-15 |
2010-08-31 |
Alcon |
Bioerodible film for ophthalmic drug delivery
|
US20060115431A1
(en)
*
|
2002-07-22 |
2006-06-01 |
Bracco Imaging S.P.A. |
Procedures of cellular labelling with paramagnetic complexes for mri applications
|
CA2497792C
(en)
|
2002-09-06 |
2014-08-05 |
Insert Therapeutics, Inc. |
Cyclodextrin-based polymers for therapeutics delivery
|
DE10244847A1
(en)
|
2002-09-20 |
2004-04-01 |
Ulrich Prof. Dr. Speck |
Medical device for drug delivery
|
CA2504604A1
(en)
*
|
2002-11-07 |
2004-05-27 |
Timothy R. Billiar |
Treatment for hemorrhagic shock
|
KR100514092B1
(en)
*
|
2002-11-23 |
2005-09-13 |
한국생명공학연구원 |
Novel composite gene delivery system consisting of cationic polymers and anionic polymers
|
IL153124A
(en)
*
|
2002-11-27 |
2010-06-30 |
Herbal Synthesis Corp |
Solid mucoadhesive composition
|
EP2359859A1
(en)
|
2002-12-09 |
2011-08-24 |
Abraxis BioScience, LLC |
Compositions comprising albumin nanoparticles and methods of delivery of pharmacological agents
|
US7311926B2
(en)
*
|
2002-12-20 |
2007-12-25 |
Battelle Memorial Institute |
Biocomposite materials and methods for making the same
|
FR2848854B1
(en)
|
2002-12-24 |
2005-03-18 |
Coletica |
PARTICLES COMPRISING A BIOPOLYMER DEGRADABLE UNDER THE EFFECT OF AN ELECTROMAGNETIC WAVE AS EMITTED BY SOLAR RADIATION
|
TWI330079B
(en)
*
|
2003-01-15 |
2010-09-11 |
Synta Pharmaceuticals Corp |
Treatment for cancers
|
US7623908B2
(en)
|
2003-01-24 |
2009-11-24 |
The Board Of Trustees Of The University Of Illinois |
Nonlinear interferometric vibrational imaging
|
JP2004290745A
(en)
*
|
2003-03-25 |
2004-10-21 |
Ajinomoto Co Inc |
Method for manufacturing microcapsule
|
US20040225022A1
(en)
*
|
2003-05-09 |
2004-11-11 |
Desai Neil P. |
Propofol formulation containing reduced oil and surfactants
|
US20040247624A1
(en)
*
|
2003-06-05 |
2004-12-09 |
Unger Evan Charles |
Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility
|
US7198777B2
(en)
*
|
2003-06-17 |
2007-04-03 |
The Board Of Trustees Of The University Of Illinois |
Optical contrast agents for optically modifying incident radiation
|
US7217410B2
(en)
*
|
2003-06-17 |
2007-05-15 |
The Board Of Trustees Of The Universtiy Of Illinois |
Surface modified protein microparticles
|
US8476010B2
(en)
|
2003-07-10 |
2013-07-02 |
App Pharmaceuticals Llc |
Propofol formulations with non-reactive container closures
|
US7217270B2
(en)
*
|
2003-09-08 |
2007-05-15 |
Mectra Labs, Inc. |
Method and material for coating electro-cautery probes and lubricating surgical instruments
|
US20050181018A1
(en)
*
|
2003-09-19 |
2005-08-18 |
Peyman Gholam A. |
Ocular drug delivery
|
JP2008504216A
(en)
*
|
2003-12-02 |
2008-02-14 |
サイトイミューン サイエンシズ インコーポレイテッド |
Methods and compositions for the production of monoclonal antibodies
|
US7610074B2
(en)
*
|
2004-01-08 |
2009-10-27 |
The Board Of Trustees Of The University Of Illinois |
Multi-functional plasmon-resonant contrast agents for optical coherence tomography
|
US8147806B2
(en)
|
2004-01-16 |
2012-04-03 |
Carnegie Mellon University |
Cellular labeling for nuclear magnetic resonance techniques
|
US20050175584A1
(en)
*
|
2004-01-28 |
2005-08-11 |
Paciotti Giulio F. |
Functionalized colloidal metal compositions and methods
|
WO2005097208A2
(en)
*
|
2004-03-26 |
2005-10-20 |
University Of Florida Research Foundation, Inc. |
Tissue oxygenation measurements
|
US7678888B2
(en)
*
|
2004-04-21 |
2010-03-16 |
Albert Einstein College Of Medicine Of Yeshiva University |
Stable oxidation resistant powdered hemoglobin, methods of preparing same, and uses thereof
|
US20090004277A1
(en)
*
|
2004-05-18 |
2009-01-01 |
Franchini Miriam K |
Nanoparticle dispersion containing lactam compound
|
AU2005287383B2
(en)
*
|
2004-05-25 |
2011-09-22 |
Chimeros, Inc. |
Self-assembling nanoparticle drug delivery system
|
US8012457B2
(en)
*
|
2004-06-04 |
2011-09-06 |
Acusphere, Inc. |
Ultrasound contrast agent dosage formulation
|
CA2568640C
(en)
*
|
2004-06-04 |
2011-08-09 |
Teva Pharmaceutical Industries Ltd. |
Pharmaceutical composition containing irbesartan
|
BRPI0512526A
(en)
|
2004-06-23 |
2008-03-11 |
Synta Pharmaceuticals Corp |
compound, pharmaceutical composition, method for treating a cancer patient and method for preparing a bis (thiohydrazide amide) di-salt
|
KR100578382B1
(en)
|
2004-07-16 |
2006-05-11 |
나재운 |
Water soluble chitosan nanoparticle for delivering a anticance agent and preparing method thereof
|
US7289840B2
(en)
|
2004-09-22 |
2007-10-30 |
Receptomon, Llc |
Method for monitoring early treatment response
|
WO2006045050A1
(en)
*
|
2004-10-19 |
2006-04-27 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH |
Methods and compositions for protecting cells from ultrasound-mediated cytolysis
|
JP4804906B2
(en)
*
|
2004-12-15 |
2011-11-02 |
ドルニエル メドテック システムズ ゲーエムベーハー |
Shock wave improved methods of cell therapy and tissue regeneration in patients with cardiovascular and neurological diseases
|
MX2007009354A
(en)
*
|
2005-02-03 |
2008-01-14 |
Epix Pharm Inc |
Steady state perfusion methods.
|
US7622102B2
(en)
*
|
2005-02-08 |
2009-11-24 |
Receptomon, Llc |
Method for monitoring early treatment response
|
CA3054535A1
(en)
*
|
2005-02-18 |
2006-08-24 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
US8735394B2
(en)
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
US7586618B2
(en)
*
|
2005-02-28 |
2009-09-08 |
The Board Of Trustees Of The University Of Illinois |
Distinguishing non-resonant four-wave-mixing noise in coherent stokes and anti-stokes Raman scattering
|
WO2006107950A2
(en)
*
|
2005-04-05 |
2006-10-12 |
Receptomon, Llc. |
Method for monitoring early treatment response
|
US7722581B2
(en)
*
|
2005-04-11 |
2010-05-25 |
Gholam A. Peyman |
Crystalline lens drug delivery
|
US20060229585A1
(en)
*
|
2005-04-11 |
2006-10-12 |
Minu, L.L.C. |
Drug delivery to the crystalline lens and other ocular structures
|
US7725169B2
(en)
*
|
2005-04-15 |
2010-05-25 |
The Board Of Trustees Of The University Of Illinois |
Contrast enhanced spectroscopic optical coherence tomography
|
BRPI0610219A2
(en)
*
|
2005-04-15 |
2010-06-08 |
Synta Pharmaceuticals Corp |
methods of treating a human being with cancer and pharmaceutical composition
|
WO2007008300A2
(en)
*
|
2005-05-31 |
2007-01-18 |
ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE |
Triblock copolymers for cytoplasmic delivery of gene-based drugs
|
ES2277743B2
(en)
|
2005-06-02 |
2008-12-16 |
Universidade De Santiago De Compostela |
NANOPARTICLES THAT INCLUDE QUITOSANE AND CYCLODEXTRINE.
|
JP4832427B2
(en)
*
|
2005-06-30 |
2011-12-07 |
アムテック株式会社 |
Instruction composition for medical device cleaning evaluation
|
US7771751B2
(en)
*
|
2005-08-31 |
2010-08-10 |
Abraxis Bioscience, Llc |
Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
|
EP3527202A1
(en)
*
|
2005-08-31 |
2019-08-21 |
Abraxis BioScience, LLC |
Compositions and methods for preparation of poorly water soluble drugs with increased stability
|
EP2206736B1
(en)
|
2005-12-05 |
2012-02-08 |
Nitto Denko Corporation |
Polyglutamate-amino acid conjugates and methods
|
US7787129B2
(en)
|
2006-01-31 |
2010-08-31 |
The Board Of Trustees Of The University Of Illinois |
Method and apparatus for measurement of optical properties in tissue
|
WO2008108776A1
(en)
*
|
2006-04-07 |
2008-09-12 |
Chimeros, Inc. |
Compositions and methods for treating b- cell malignancies
|
US7744928B2
(en)
*
|
2006-04-14 |
2010-06-29 |
Advanced Cardiovascular Systems, Inc. |
Methods and compositions for treatment of lesioned sites of body vessels
|
WO2007120911A2
(en)
|
2006-04-14 |
2007-10-25 |
Carnegie Mellon University |
Cellular labeling and quantification for nuclear magnetic resonance techniques
|
US7458953B2
(en)
*
|
2006-06-20 |
2008-12-02 |
Gholam A. Peyman |
Ocular drainage device
|
JP2010501562A
(en)
|
2006-08-21 |
2010-01-21 |
シンタ ファーマシューティカルズ コーポレーション |
Compounds for treating proliferative disorders
|
US20100055459A1
(en)
*
|
2006-08-30 |
2010-03-04 |
Liquidia Technologies, Inc. |
Nanoparticles Having Functional Additives for Self and Directed Assembly and Methods of Fabricating Same
|
WO2008027445A2
(en)
*
|
2006-08-31 |
2008-03-06 |
Synta Pharmaceuticals Corp. |
Combination with bis(thiohydrazide amides) for treating cancer
|
US20080280987A1
(en)
*
|
2006-08-31 |
2008-11-13 |
Desai Neil P |
Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
|
US9498528B2
(en)
*
|
2006-09-13 |
2016-11-22 |
Genzyme Corporation |
Treatment of multiple sclerosis (MS)
|
ES2700074T3
(en)
|
2006-12-14 |
2019-02-13 |
Abraxis Bioscience Llc |
Therapy for breast cancer based on the status of the hormone receptors with nanoparticles that comprise taxane
|
US20080176958A1
(en)
|
2007-01-24 |
2008-07-24 |
Insert Therapeutics, Inc. |
Cyclodextrin-based polymers for therapeutics delivery
|
US20080181852A1
(en)
*
|
2007-01-29 |
2008-07-31 |
Nitto Denko Corporation |
Multi-functional Drug Carriers
|
RU2483714C2
(en)
*
|
2007-03-07 |
2013-06-10 |
АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи. |
Nanoparticle, containing rapamycin and albumin as anti-cancer agent
|
DE102007015598A1
(en)
*
|
2007-03-29 |
2008-10-02 |
Heinrich-Heine-Universität Düsseldorf |
Use of fluorochemical compounds for diagnostic purposes using imaging techniques
|
EP2144600A4
(en)
*
|
2007-04-04 |
2011-03-16 |
Massachusetts Inst Technology |
Poly (amino acid) targeting moieties
|
AU2008236566A1
(en)
*
|
2007-04-09 |
2008-10-16 |
Chimeros, Inc. |
Self-assembling nanoparticle drug delivery system
|
EP2144596A4
(en)
*
|
2007-04-10 |
2012-06-13 |
Saint Simeon Lda |
Novel compositions containing lysozyme and c-1/c-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology
|
CN104800856A
(en)
*
|
2007-04-10 |
2015-07-29 |
日东电工株式会社 |
Multi-functional polyglutamate drug carriers
|
EP2537539B1
(en)
*
|
2007-04-13 |
2019-04-03 |
Kuros Biosurgery AG |
Polymeric Tissue Sealant
|
CA2686736A1
(en)
*
|
2007-05-03 |
2008-11-13 |
Abraxis Bioscience, Llc |
Nanoparticle compositions comprising rapamycin for treating pulmonary hypertension
|
CN101730549B
(en)
*
|
2007-05-09 |
2015-12-09 |
日东电工株式会社 |
The polymer be combined with platinum medicine
|
EP2155255B1
(en)
|
2007-05-09 |
2013-08-14 |
Nitto Denko Corporation |
Compositions that include a hydrophobic compound and a polyamino acid conjugate
|
US8927019B2
(en)
|
2007-06-01 |
2015-01-06 |
Abraxis Bioscience, Llc |
Methods and compositions for treating recurrent cancer
|
JP5645658B2
(en)
|
2007-07-10 |
2014-12-24 |
カーネギー メロン ユニバーシティー |
Compositions and methods for producing cell labels for nuclear magnetic resonance technology
|
JP2010539245A
(en)
*
|
2007-09-14 |
2010-12-16 |
日東電工株式会社 |
Drug carrier
|
KR20100123674A
(en)
*
|
2007-09-21 |
2010-11-24 |
싸이티뮨 사이언스, 인크. |
Nanotherapeutic colloidal metal compositions and methods
|
US20110014118A1
(en)
*
|
2007-09-21 |
2011-01-20 |
Lawrence Tamarkin |
Nanotherapeutic colloidal metal compositions and methods
|
DK2644192T3
(en)
|
2007-09-28 |
2017-06-26 |
Pfizer |
Cancer cell targeting using nanoparticles
|
CA2706700A1
(en)
|
2007-11-08 |
2009-05-14 |
Cytimmune Sciences, Inc. |
Compositions and methods for generating antibodies
|
US8906855B2
(en)
|
2007-12-22 |
2014-12-09 |
Vivacelle Bio, Inc. |
Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
|
US8618056B2
(en)
|
2007-12-22 |
2013-12-31 |
Cuthbert O. Simpkins |
Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
|
US8063020B2
(en)
*
|
2007-12-22 |
2011-11-22 |
Simpkins Cuthbert O |
Resuscitation fluid
|
US8115934B2
(en)
|
2008-01-18 |
2012-02-14 |
The Board Of Trustees Of The University Of Illinois |
Device and method for imaging the ear using optical coherence tomography
|
US7751057B2
(en)
|
2008-01-18 |
2010-07-06 |
The Board Of Trustees Of The University Of Illinois |
Magnetomotive optical coherence tomography
|
US8983580B2
(en)
|
2008-01-18 |
2015-03-17 |
The Board Of Trustees Of The University Of Illinois |
Low-coherence interferometry and optical coherence tomography for image-guided surgical treatment of solid tumors
|
US8986253B2
(en)
|
2008-01-25 |
2015-03-24 |
Tandem Diabetes Care, Inc. |
Two chamber pumps and related methods
|
AU2009222230A1
(en)
*
|
2008-03-06 |
2009-09-11 |
Nitto Denko Corporation |
Polymer paclitaxel conjugates and methods for treating cancer
|
CA2721153C
(en)
*
|
2008-04-10 |
2018-10-02 |
Abraxis Bioscience, Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
JP2011517683A
(en)
*
|
2008-04-10 |
2011-06-16 |
アブラクシス バイオサイエンス, エルエルシー |
Composition of hydrophobic taxane derivative and use thereof
|
TWI541020B
(en)
|
2008-04-17 |
2016-07-11 |
巴克斯歐塔公司 |
Biologically active peptides
|
DE102008045152A1
(en)
*
|
2008-07-09 |
2010-01-14 |
Universität Duisburg-Essen |
Artificial oxygen carriers and their use
|
CN101642570B
(en)
*
|
2008-08-07 |
2012-09-05 |
江苏大学附属医院 |
Application of carbon monoxide-releasing molecules and heparin in preparing medicament for treating sepsis
|
US8408421B2
(en)
|
2008-09-16 |
2013-04-02 |
Tandem Diabetes Care, Inc. |
Flow regulating stopcocks and related methods
|
EP2334234A4
(en)
|
2008-09-19 |
2013-03-20 |
Tandem Diabetes Care Inc |
Solute concentration measurement device and related methods
|
US20100114057A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Medtronic, Inc. |
System and method for delivery of biologic agents
|
US8870848B2
(en)
|
2008-10-31 |
2014-10-28 |
Medtronic, Inc. |
System and method for delivery of biologic agents
|
JP5814793B2
(en)
|
2008-11-25 |
2015-11-17 |
エコール ポリテクニク フェデラル ド ローザンヌ(エーペーエフエル) |
Block copolymer and use thereof
|
KR101977846B1
(en)
|
2008-12-19 |
2019-05-14 |
박스알타 인코퍼레이티드 |
Tfpi inhibitors and methods of use
|
US9250106B2
(en)
|
2009-02-27 |
2016-02-02 |
Tandem Diabetes Care, Inc. |
Methods and devices for determination of flow reservoir volume
|
US8573027B2
(en)
|
2009-02-27 |
2013-11-05 |
Tandem Diabetes Care, Inc. |
Methods and devices for determination of flow reservoir volume
|
US11235062B2
(en)
*
|
2009-03-06 |
2022-02-01 |
Metaqor Llc |
Dynamic bio-nanoparticle elements
|
US11096901B2
(en)
|
2009-03-06 |
2021-08-24 |
Metaqor Llc |
Dynamic bio-nanoparticle platforms
|
WO2010120874A2
(en)
|
2009-04-14 |
2010-10-21 |
Chimeros, Inc. |
Chimeric therapeutics, compositions, and methods for using same
|
RS59896B1
(en)
|
2009-04-15 |
2020-03-31 |
Abraxis Bioscience Llc |
Prion-free nanoparticle compositions and methods
|
EP2451496B1
(en)
|
2009-07-10 |
2015-07-22 |
Boston Scientific Scimed, Inc. |
Use of nanocrystals for a drug delivery balloon
|
CA2921304C
(en)
|
2009-07-30 |
2018-06-05 |
Tandem Diabetes Care, Inc. |
Infusion pump system with disposable cartridge having pressure venting and pressure feedback
|
US10099227B2
(en)
|
2009-08-25 |
2018-10-16 |
Nanoshell Company, Llc |
Method and apparatus for continuous removal of sub-micron sized particles in a closed loop liquid flow system
|
US10751464B2
(en)
|
2009-08-25 |
2020-08-25 |
Nanoshell Company, Llc |
Therapeutic retrieval of targets in biological fluids
|
US11285494B2
(en)
|
2009-08-25 |
2022-03-29 |
Nanoshell Company, Llc |
Method and apparatus for continuous removal of sub-micron sized particles in a closed loop liquid flow system
|
CN102625710A
(en)
*
|
2009-08-25 |
2012-08-01 |
艾格尼丝·奥斯塔芬 |
Synthesis of oxygen carrying, turbulence resistant, high density submicron particulates
|
WO2011062614A1
(en)
*
|
2009-11-20 |
2011-05-26 |
Tonix Pharmaceuticals, Inc. |
Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine
|
JP6220126B2
(en)
*
|
2009-11-23 |
2017-10-25 |
セルリアン・ファーマ・インコーポレイテッド |
Polymers based on cyclodextrins for therapeutic delivery
|
WO2011069082A2
(en)
*
|
2009-12-04 |
2011-06-09 |
The Regents Of The University Of Michigan |
Red blood cell-mimetic particles and methods for making and use thereof
|
EP2531173B1
(en)
*
|
2010-02-03 |
2018-09-26 |
Oncbiomune, L.L.C. |
Taxane- and taxoid-protein compositions
|
TWI438009B
(en)
*
|
2010-02-19 |
2014-05-21 |
Teikoku Pharma Usa Inc |
Taxane pro-emulsion formulations and methods making and using the same
|
CN103025345B
(en)
|
2010-03-19 |
2016-01-20 |
巴克斯特国际公司 |
TFPI inhibitor and using method
|
CA2793536C
(en)
|
2010-03-26 |
2019-10-01 |
Abraxis Bioscience, Llc |
Use of nanoparticles comprising a taxane and albumin in the treatment of hepatocellular carcinoma
|
MX2012011155A
(en)
|
2010-03-29 |
2012-12-05 |
Abraxis Bioscience Llc |
Methods of enhancing drug delivery and effectiveness of therapeutic agents.
|
HUE030207T2
(en)
|
2010-03-29 |
2017-04-28 |
Abraxis Bioscience Llc |
Methods of treating cancer
|
ES2652509T3
(en)
|
2010-05-03 |
2018-02-02 |
Teikoku Pharma Usa, Inc. |
Non-aqueous taxane proemulsion formulations and methods for preparing and using them
|
WO2011140193A1
(en)
*
|
2010-05-04 |
2011-11-10 |
Massachusetts Institute Of Technology |
Implantable dissolved oxygen sensor and methods of use
|
AU2011261685B2
(en)
|
2010-06-04 |
2016-02-11 |
Abraxis Bioscience, Llc |
Methods of treatment of pancreatic cancer
|
US20110319389A1
(en)
|
2010-06-24 |
2011-12-29 |
Tonix Pharmaceuticals, Inc. |
Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine
|
ES2386177B1
(en)
*
|
2010-09-21 |
2013-09-23 |
Lipotec, S.A. |
NANOCAPSULES CONTAINING MICROEMULSIONS
|
US9482861B2
(en)
|
2010-10-22 |
2016-11-01 |
The Regents Of The University Of Michigan |
Optical devices with switchable particles
|
TW201242974A
(en)
|
2010-11-30 |
2012-11-01 |
Gilead Pharmasset Llc |
Compounds
|
SG10201606406PA
(en)
|
2011-04-28 |
2016-09-29 |
Abraxis Bioscience Llc |
Intravascular delivery of nanoparticle compositions and uses thereof
|
CA2838387A1
(en)
|
2011-06-06 |
2012-12-13 |
Chevron Phillips Chemical Company Lp |
Use of metallocene compounds for cancer treatment
|
CA2838833A1
(en)
|
2011-06-10 |
2012-12-13 |
Biogen Idec Ma Inc. |
Pro-coagulant compounds and methods of use thereof
|
US9504759B2
(en)
|
2011-08-11 |
2016-11-29 |
Bar-Ilan University |
Surface modified proteinaceous spherical particles and uses thereof
|
JP2014527072A
(en)
|
2011-09-09 |
2014-10-09 |
バイオメド リアルティー, エル.ピー. |
Methods and compositions for controlling the assembly of viral proteins
|
WO2013084207A1
(en)
|
2011-12-07 |
2013-06-13 |
Universidade Do Minho |
Formulations for micelle formation comprising a protein and methods preparation thereof
|
RU2705998C2
(en)
|
2011-12-14 |
2019-11-13 |
АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи |
Use of polymer excipients for lyophilization or freezing of particles
|
GB201221305D0
(en)
*
|
2012-11-27 |
2013-01-09 |
Greater Glasgow Health Board |
Improved methods of assessing metabolic function
|
WO2013141965A1
(en)
|
2012-03-21 |
2013-09-26 |
Baxter International Inc. |
Tfpi inhibitors and methods of use
|
WO2013151682A1
(en)
|
2012-04-06 |
2013-10-10 |
Children's Medical Center Corporation |
Process for forming microbubbles with high oxygen content and uses thereof
|
US20150132227A1
(en)
*
|
2012-04-18 |
2015-05-14 |
University Of Utah Research Foundation |
Novel echogenic contrast agents
|
US9335910B2
(en)
|
2012-04-23 |
2016-05-10 |
Tandem Diabetes Care, Inc. |
System and method for reduction of inadvertent activation of medical device during manipulation
|
US9180242B2
(en)
|
2012-05-17 |
2015-11-10 |
Tandem Diabetes Care, Inc. |
Methods and devices for multiple fluid transfer
|
US9715327B2
(en)
|
2012-06-07 |
2017-07-25 |
Tandem Diabetes Care, Inc. |
Preventing inadvertent changes in ambulatory medical devices
|
AU2013270682A1
(en)
|
2012-06-08 |
2014-12-11 |
Biogen Ma Inc. |
Procoagulant compounds
|
CN103565745A
(en)
|
2012-08-10 |
2014-02-12 |
德克萨斯州大学系统董事会 |
Neuroprotective liposome compositions and methods for treatment of stroke
|
JO3685B1
(en)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
Non-aqueous taxane nanodispersion formulations and methods of using the same
|
US20140094432A1
(en)
|
2012-10-02 |
2014-04-03 |
Cerulean Pharma Inc. |
Methods and systems for polymer precipitation and generation of particles
|
US9149455B2
(en)
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
WO2014077629A1
(en)
*
|
2012-11-15 |
2014-05-22 |
재단법인 유타 인하 디디에스 및 신의료기술개발공동연구소 |
Biodegradable microbeads with improved anticancer drug adsorptivity, containing albumin and dextran sulfate, and preparation method therefor
|
CA2892227C
(en)
|
2012-11-30 |
2020-12-15 |
Novomedix, Llc |
Substituted biaryl sulfonamides and the use thereof
|
US9511046B2
(en)
|
2013-01-11 |
2016-12-06 |
Abraxis Bioscience, Llc |
Methods of treating pancreatic cancer
|
CN110279864A
(en)
|
2013-03-12 |
2019-09-27 |
阿布拉科斯生物科学有限公司 |
The method for treating lung cancer
|
US9101745B2
(en)
|
2013-03-14 |
2015-08-11 |
Sonogene Llc |
Sonochemical induction of ABCA1 expression and compositions therefor
|
US9173998B2
(en)
|
2013-03-14 |
2015-11-03 |
Tandem Diabetes Care, Inc. |
System and method for detecting occlusions in an infusion pump
|
NZ630213A
(en)
|
2013-03-14 |
2017-05-26 |
Abraxis Bioscience Llc |
Methods of treating bladder cancer
|
WO2014145156A2
(en)
|
2013-03-15 |
2014-09-18 |
Tonix Pharmaceuticals, Inc. |
Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
|
WO2014144364A1
(en)
|
2013-03-15 |
2014-09-18 |
Children's Medical Center Corporation |
Gas-filled stabilized particles and methods of use
|
US9421329B2
(en)
|
2013-03-15 |
2016-08-23 |
Tandem Diabetes Care, Inc. |
Infusion device occlusion detection system
|
JP6625966B2
(en)
*
|
2013-03-15 |
2019-12-25 |
ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム |
Noble gas-rich liquids and methods for their preparation and use
|
US20160067276A1
(en)
*
|
2013-03-15 |
2016-03-10 |
Children's Medical Center Corporation |
Hollow particles encapsulating a biological gas and methods of use
|
AU2014302771A1
(en)
*
|
2013-06-24 |
2016-01-28 |
Celgene Corporation |
Methods of expanding T cells
|
US10711106B2
(en)
|
2013-07-25 |
2020-07-14 |
The University Of Chicago |
High aspect ratio nanofibril materials
|
US20150140537A1
(en)
*
|
2013-11-19 |
2015-05-21 |
Spectra Group Limited, Inc. |
Blood simulant for simulatoin-based medical trauma training
|
WO2015018380A2
(en)
|
2014-07-03 |
2015-02-12 |
Cspc Zhongqi Pharmaceutical Technology(Shijiazhuang)Co., Ltd. |
Therapeutic nanoparticles and the preparation methods thereof
|
SG10201902499VA
(en)
|
2014-09-03 |
2019-04-29 |
Genesegues Inc |
Therapeutic nanoparticles and related compositions, methods and systems
|
BR112017005231A2
(en)
|
2014-09-18 |
2018-03-13 |
Tonix Pharma Holdings Ltd |
eutectic formulations of cyclobenzaprine hydrochloride
|
US10527604B1
(en)
|
2015-03-05 |
2020-01-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
|
US10705070B1
(en)
|
2015-03-05 |
2020-07-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
|
EP3313401B1
(en)
|
2015-06-29 |
2021-10-06 |
Abraxis BioScience, LLC |
Nanoparticles comprising sirolimus and an albumin for use in treating epithelioid cell tumors
|
CN105901706B
(en)
*
|
2016-04-21 |
2019-01-25 |
长江大学 |
A kind of preparation method of the anti-oxidant hydrolysate of goose blood and its microcapsules
|
TR201606102A2
(en)
*
|
2016-05-10 |
2016-10-21 |
Tolgay Tuyan Ilhan |
A DEVICE THAT CAN MEASURE OXYGEN CONCENTRATION IN INTRA-Abdominal CANCER TREATMENTS AND MAKES CHANGES ON OXYGEN DOSAGE GIVEN
|
US11147890B2
(en)
|
2017-02-28 |
2021-10-19 |
Children's Medical Center Corporation |
Stimuli-responsive particles encapsulating a gas and methods of use
|
IL275289B2
(en)
|
2017-12-11 |
2024-01-01 |
Tonix Pharma Holdings Ltd |
Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions
|
MX2020009740A
(en)
|
2018-03-20 |
2021-01-20 |
Abraxis Bioscience Llc |
Methods of treating central nervous system disorders via administration of nanoparticles of an mtor inhibitor and an albumin.
|
WO2020114615A1
(en)
|
2018-12-07 |
2020-06-11 |
Baxalta GmbH |
Bispecific antibodies binding factor ixa and factor x
|
WO2020115283A1
(en)
|
2018-12-07 |
2020-06-11 |
Baxalta GmbH |
Bispecific antibodies binding factor ixa and factor x
|
WO2021067495A1
(en)
*
|
2019-10-04 |
2021-04-08 |
The Regents Of The University Of Colorado, A Body Corporate |
Micron sized droplets with solid endoskeleton or exoskeleton which tunes the thermal stability of the liquid droplets
|
MX2022004989A
(en)
|
2019-10-28 |
2022-07-21 |
Abraxis Bioscience Llc |
Pharmaceutical compositions of albumin and rapamycin.
|
CN112891566A
(en)
*
|
2019-12-04 |
2021-06-04 |
中国科学院宁波工业技术研究院慈溪生物医学工程研究所 |
Nano material, preparation method thereof and contrast agent containing nano material
|
US11366091B2
(en)
*
|
2020-02-11 |
2022-06-21 |
Saudi Arabian Oil Company |
High temperature high pressure (HTHP) cell in sum frequency generation (SFG) spectroscopy for oil/brine interface analysis with reservoir conditions and dynamic compositions
|
CN112546406B
(en)
*
|
2020-11-20 |
2022-04-22 |
广东药科大学 |
Micro-robot drug delivery device and drug delivery system
|
WO2023164487A1
(en)
*
|
2022-02-22 |
2023-08-31 |
Brown University |
Compositions and methods to achieve systemic uptake of particles following oral or mucosal administration
|
WO2024046999A1
(en)
|
2022-08-31 |
2024-03-07 |
Johann Wolfgang Goethe-Universität Frankfurt am Main |
Lecithin-modified nanoscale oxygen carriers (lenox)
|